CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 19 Issue: 3, April 2020



Meet Our Editorial Board Member free to download

Volume:19   Issue: 3
Pp: 163-164
Caterina Bendotti
DOI: 10.2174/187152731903200625151510
Published on: 25 June, 2020



Targeting the PI3K/AKT/mTOR Signaling Pathway in Primary Central Nervous System Lymphoma: Current Status and Future Prospects

Volume:19   Issue: 3
Pp: 165-173
Xiaowei Zhang and Yuanbo Liu *
DOI: 10.2174/1871527319666200517112252
Published on: 17 May, 2020




Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches

Volume:19   Issue: 3
Pp: 174-183
Subrat Kumar Bhattamisra*, Lee Yuen Shin, Hanis Izzati Binti Mohd Saad, Vikram Rao, Mayuren Candasamy, Manisha Pandey and Hira Choudhury
DOI: 10.2174/1871527319666200518102130
Published on: 17 May, 2020




The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease

Volume:19   Issue: 3
Pp: 184-194
Hirak Shah, Ashish Patel*, Vruti Parikh, Afzal Nagani, Bhargav Bhimani, Umang Shah and Tushar Bambharoliya
DOI: 10.2174/1871527319666200526144141
Published on: 26 May, 2020




Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson’s Disease

Volume:19   Issue: 3
Pp: 195-206
Andrew Schneider, Adam T. Sari, Hasan Alhaddad and Youssef Sari*
DOI: 10.2174/1871527319666200525011110
Published on: 24 May, 2020




A Pivotal Role of the Nrf2 Signaling Pathway in Spinal Cord Injury: A Prospective Therapeutics Study

Volume:19   Issue: 3
Pp: 207-219
Saeed Samarghandian, Ali Mohammad Pourbagher-Shahri, Milad Ashrafizadeh, Haroon Khan, Fatemeh Forouzanfar, Hamed Aramjoo and Tahereh Farkhondeh*
DOI: 10.2174/1871527319666200604175118
Published on: 04 June, 2020




The Combination of rTMS and Pharmacotherapy on In Vitro Models: A Mini-Review

Volume:19   Issue: 3
Pp: 220-226
Chryssa Pourzitaki*, Ioannis Dardalas, Frideriki Poutoglidou, Dimitrios Kouvelas and Vasilios K. Kimiskidis
DOI: 10.2174/1871527319666200518100716
Published on: 17 May, 2020




In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models

Volume:19   Issue: 3
Pp: 227-240
Veronique Riban *, Johann Meunier , Dorothee Buttigieg, Vanessa Villard and Marc Verleye
DOI: 10.2174/1871527319666200601151007
Published on: 01 June, 2020